- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
U.S. Senate Committee on Appropriations Votes on Leahy Amendment
Washington D.C. -- This morning, the Senate Committee on Appropriations voted to include an amendment introduced by Senator Patrick Leahy (D-VT) in the FY2018 Commerce, Justice, Science and Related Agencies Appropriations bill. The amendment prohibits the use of Federal funds to interfere with medical cannabis patients and programs that are in compliance with state medical cannabis laws.
The inclusion of this amendment in the final appropriations package would allow state programs to continue the protections afforded to them in the 2015 budget, the 2016 budget, and the 2017 continuing resolution.
“This success of the Leahy medical cannabis amendment acknowledges, yet again, that the federal government should not interfere with state medical cannabis programs,” said Steph Sherer Americans for Safe Access Executive Director. “The passage of the Leahy medical cannabis amendment also shows that Senate support exists for the central elements of the CARERS Act. The CARERS Act would make the protections in Leahy medical cannabis amendment permanent and create a much needed framework for research and federal and state cooperation.”
“We are thrilled at this vote,” said Beth Collins, Senior Director of Government Relations and External Affairs at Americans for Safe Access. “With 91 Americans a day dying from opioid overdose, and a nearly 25% decrease in opioid overdose deaths in states with medical cannabis programs, it is crucial that states are able to continue without federal interference.”
When introducing the amendment, Senator Leahy stated, “We have more important things for the justice department to do than tracking down physicians or epileptics who are using medical marijuana legally in their state.”